Mr. Joseph Passarelli
Roche Diagnostics Corporation
Research and Development
Joseph Passarelli is Senior Director, Scientific Relations at Roche Diagnostics Corporation. In this role, he represents Roche as a scientific liaison to professional societies and standard- and guideline-setting organizations worldwide. He has worked both domestically and internationally in research and development for more than 35 years and has experience in discovery, research, development, laboratory management, technology transfer, regulatory submissions, and market commercialization. His scientific background includes developing immunoassays that use multiple technologies for homogenous laboratory-based testing platforms. He is recognized in the fields of drugs of abuse testing and therapeutic drug monitoring. Before assuming his current role, Mr. Passarelli was head of Roche Diagnostics Research and Development for these scientific disciplines.
Mr. Passarelli is Secretary to the International Federation of Clinical Chemistry and Laboratory Medicine’s Scientific Division Executive Committee. Prior to this role he served as SD’s corporate member. He is also a member of the Harmonization Oversight Group of the International Consortium for Harmonization of Clinical Laboratory Results.
In addition to his activities with the IFCC, Mr. Passarelli has been active with Clinical and Laboratory Standards Institute (CLSI) for several years. Currently he serves on the CLSI Board of Directors and prior to this, as a member of the CLSI Consensus Council. He also serves as a member of the Executive Committee of the US Technical Advisory Group to the International Organization for Standardization (ISO) Technical Committee 212 – Clinical laboratory testing and in vitro diagnostic test systems. His professional interests include educating and promoting the value of standardization and harmonization through the use of recognized standards and guidelines and collaborate extensively with professional organizations worldwide. Mr. Passarelli is a member of the American Association for Clinical Chemistry (AACC) Industry Division and received the 2014 AACC Presidential Citation for his contributions to laboratory medicine and education.